Synthesis and Pharmacological Evaluation of Ring-Methylated Derivatives of 3,4-(Methylenedioxy)amphetamine (MDA)

Merck Company, 1912, Dialkyloxyaryl- und Alkylendioxyarylaminopropanen bzw. deren am Stickstoff monoalkylieren Derivaten. German Patent No. 274,350

Nichols D. E., 1984, Hallucinogens:  Neurochemical, Behavioral, and Clinical Perspectives

Shulgin A. T, 1986, J. Psychoact. Drugs, 18, 304, 10.1080/02791072.1986.10472361

Nichols D. E., 1986, J. Med. Chem., 29, 2015

Titeler M., 1988, Psychopharmacology, 94, 216, 10.1007/BF00176847

Johnson M. P., 1991, Eur. J. Pharmacol., 200, 16, 10.1016/0014-2999(91)90659-E

Nichols D. E., 1993, Drug Des. Discovery, 9, 312

McKenna D. J., 1991, Pharmacol. Biochem. Behav., 38, 512, 10.1016/0091-3057(91)90005-M

Barfknecht C. F., 1975, J. Med. Chem., 18, 210

Nichols D. E., 1990, J. Med. Chem., 33, 710, 10.1021/jm00164a037

Shulgin, A.; Shulgin, A.PIHKAL; Transform Press:  Berkeley, CA, 1991; pp 710−711; ISBN 0-9630096-0-5.

Comins D. L., 1984, J. Org. Chem., 49, 1083

Shulgin, A.; Shulgin, A.PIHKAL; Transform Press:  Berkeley, CA, 1991; p 709; ISBN 0-9630096-0-5.

Sinhababu A. K., 1985, J. Med. Chem., 28, 1279, 10.1021/jm00147a027

Monte A. P., 1993, J. Med. Chem., 36, 3706, 10.1021/jm00075a027

Monte A. P., 1996, J. Med. Chem., 39, 2961, 10.1021/jm960199j

Johnson M. P., 1991, Neuropharmacology, 30, 822

Nichols D. E., 1997, Handbook of Experimental Pharmacology. Serotoninergic Neurons and 5-HT Receptors in the CNS

Nichols D. E., 1991, Pharmacol. Biochem. Behav., 38, 135, 10.1016/0091-3057(91)90601-W

Huang X., 1992, p-Methylthioamphetamine Is a Potent New Nonneurotoxic Serotonin-Releasing Agent. Eur. J. Pharmacol., 229, 38

Steele T. D., 1987, Biochem. Pharmacol., 36, 2297, 10.1016/0006-2952(87)90594-6

Litchfield J. T., 1949, J. Pharmacol. Exp. Ther., 96, 113

Johnson M. P., 1991, J. Med. Chem., 34, 1668, 10.1021/jm00109a020

Mathis C. A., 1988, J. Labeled Compd. Radiopharm., 25, 1265, 10.1002/jlcr.2580251112